perfil lipídico y alteraciones menstruales en mujeres que usan el anticonceptivo inyectable combinado mesigyna lipid profile and menstrual disorders in women using contraceptive injection combined mesigyne

Clicks: 339
ID: 139769
2004
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #17 of 89 articles by views in Frontiers in endocrinology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
La anticoncepción hormonal con inyectables hormonales de acción prolongada representa una alternativa ya bastante establecida. Nos propusimos conocer las alteraciones que sobre el metabolismo lipídico y sobre el patrón menstrual provocaba la utilización del anticonceptivo inyectable combinado mensual (AICs) Mesigyna schering AG. Se incluyó en el estudio a 75 mujeres no embarazadas que deseaban controlar su fertilidad. Se hicieron determinaciones de coleterol total, c- HDL, c- LDL, triglicéridos, Lpa. Como resultados obtuvimos que el c-HDL tuvo una ligera tendencia al aumento a partir del segundo año de uso del AICs Mesigyna, la Lpa estuvo elevada en el 16% del total de pacientes. En cuanto al patrón menstrual la regularidad del ciclo se presentó en el 81.3% del total de mujeres al finalizar el estudio. Concluimos que la aplicación del AICs Mesigyna produce alteraciones del ciclo menstrual invariablemente así como se demuestra su papel antiaterogénico por sus efectos metabólicos sobre el perfil lipídico.
Hormonal contraception with long-acting hormonal injections represrnt an established alternative. This study was aimed at knowing the disturbances that mently-birth control injection combined with mesigyna scherring AG provoked over lipid metabolism and menstrual pattern, to investigate it, 75 non-pregnant women who wished to control their fertility were included in the study. Total cholesterol, C-HDL, C-LDL, triglycerides and Ipa were determined showing that C-HDL had a slightly increase-trend from the second year of the use of AICs Mesigyna, the Lpa increased in the 16% of the total of patients. Menstrual pattern had regularity in its cycle-81.3 % of the total of women at the end of the study- concluding that the use of AICs Mesigyna produces disturbances on menstrual cycle invariably, demonstrating its antiatherogenic role due to its metabolic effects over lipid profile.
Reference Key
espinosa2004revistaperfil Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Ileana Suárez Espinosa;Ramón Valdés Carrillo
Journal Frontiers in endocrinology
Year 2004
DOI
DOI not found
URL
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942004000100007
Keywords
lipids contraception lipoproteinsmedicinemedicine (general)

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.